Sino Biological™ FCER2 Recombinant Human Protein, N-His Tag

This recombinant protein was expressed from a DNA sequence encoding the human CD23 isoform 2 (P06734-1) extracellular domain (Asp 48-Ser 321) fused to a polyhistidine tag at the N-terminus

Brand: Invitrogen

Manufacturer Part Number: 10261H07H50


UNSPSC: 12352202

Code: NEW

Additional Details:
Additional Details: Weight: 0.01000kg

Disclaimers: For Research Use Only. Not for use in diagnostic procedures.

Product Code. 15285035

Quantity Price
1 £218.00 / 50µg
Estimated Shipment date
from Supplier 28-10-2016
Add to basket

Description and Specification


For Use With (Application) Proteins, Expression, Isolation & Analysis; Enzyme & Protein Activity Assays; Protein Assay Controls, Reference Standards & Accessories
Format Lyophilized
Gene ID (Entrez) 2208
Molecular Weight 33.2kDa
Purification Method PAGE
Purity ≥90% by SDS-PAGE
Quantity 50μg
Storage Requirements Store at -20°C. Store aliquots under sterile conditions at -20°C. Avoid repeated freeze-thaw cycles.
Termination N-Terminal
Structural Form Truncated/Recombinant
Endotoxin Concentration <1 EU/μg
Gene Alias CLEC-6, CLEC6, CLECSF8, MCL, mgC40078, MPCL
Common Name Fc fragment of IgE, low affinity II, receptor for (CD23)
Gene Symbol FCER2
Protein Tag His Tag
Validated Application Assay Standard
Protein Family CD Proteins
Expression System Mammalian

Fc Fragment of IgE, low affinity II receptor (FCER2/CD23), recombinant human protein is supplied as a lyophilized powder. It is suitable for use in analysis of protein structure. In general, recombinant proteins can also be used as an immunogen, as a protein standard, or in cell biology research applications.
  • Activity: The activity of this protein has not been tested
  • Formulation: Lyophilized in PBS, pH 7.4, 5% Mannitol, 5% Trehalose, 0.02% Tween 80
  • Reconstitution: Dissolve the protein in sterile double distilled water to a concentration of 0.2mg/mL or lower; aliquot and use as soon as possible

This protein is manufactured by Sino Biological Inc.